• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

局限型脉络膜血管瘤中质子束与光动力疗法对视功能保护的疗效比较。

COMPARATIVE EFFECTIVENESS OF PROTON BEAM VERSUS PHOTODYNAMIC THERAPY TO SPARE THE VISION IN CIRCUMSCRIBED CHOROIDAL HEMANGIOMA.

机构信息

Service d'Ophtalmologie, Hôpital universitaire de la Croix-Rousse, Hospices Civils de Lyon, France.

Laboratoire UMR-CNRS 5510 Matéis, Villeurbane, France.

出版信息

Retina. 2021 Feb 1;41(2):277-286. doi: 10.1097/IAE.0000000000002843.

DOI:10.1097/IAE.0000000000002843
PMID:32404844
Abstract

PURPOSE

The aim of this study was to compare the functional and anatomical effectiveness of photodynamic therapy (PDT) versus proton beam therapy (PBT) in a real-life setting for the treatment of circumscribed choroidal hemangioma.

METHODS

A total of 191 patients with a diagnosis of circumscribed choroidal hemangioma and treated by PBT or PDT were included for analyses.

RESULTS

The 119 patients (62.3%) treated by PDT were compared with the 72 patients treated by PBT. The final best-corrected visual acuity did not differ significantly between the two groups (P = 0.932) and final thickness was lower in the PBT compared with the PDT group (P = 0.001). None of the patients treated by PBT needed second-line therapy. In comparison, 53 patients (44.5%) initially treated by PDT required at least one other therapy and were associated with worse final best-corrected visual acuity (P = 0.037). In multivariate analysis, only an initial thickness greater than 3 mm remained significant (P = 0.01) to predict PDT failure with an estimated odds ratio of 2.72, 95% confidence interval (1.25-5.89).

CONCLUSION

Photodynamic therapy and PBT provide similar anatomical and functional outcomes for circumscribed choroidal hemangioma ≤3 mm, although multiple sessions are sometimes required for PDT. For tumors >3 mm, PBT seems preferable because it can treat the tumor in only 1 session with better functional and anatomical outcomes.

摘要

目的

本研究旨在比较光动力疗法(PDT)与质子束疗法(PBT)在治疗局限性脉络膜血管瘤的实际情况下的功能和解剖效果。

方法

共纳入 191 例经 PBT 或 PDT 治疗的局限性脉络膜血管瘤患者进行分析。

结果

119 例(62.3%)接受 PDT 治疗的患者与 72 例接受 PBT 治疗的患者进行比较。两组最终最佳矫正视力无显著差异(P = 0.932),PBT 组最终厚度低于 PDT 组(P = 0.001)。无 PBT 治疗的患者需要二线治疗。相比之下,53 例(44.5%)最初接受 PDT 治疗的患者至少需要另一种治疗,且与最终最佳矫正视力较差相关(P = 0.037)。多变量分析显示,仅初始厚度大于 3mm 仍与 PDT 失败显著相关(P = 0.01),估计优势比为 2.72,95%置信区间(1.25-5.89)。

结论

对于厚度≤3mm 的局限性脉络膜血管瘤,PDT 和 PBT 提供相似的解剖和功能结果,尽管 PDT 有时需要多次治疗。对于厚度>3mm 的肿瘤,PBT 似乎更可取,因为它可以仅用 1 次治疗即可治疗肿瘤,且具有更好的功能和解剖结果。

相似文献

1
COMPARATIVE EFFECTIVENESS OF PROTON BEAM VERSUS PHOTODYNAMIC THERAPY TO SPARE THE VISION IN CIRCUMSCRIBED CHOROIDAL HEMANGIOMA.局限型脉络膜血管瘤中质子束与光动力疗法对视功能保护的疗效比较。
Retina. 2021 Feb 1;41(2):277-286. doi: 10.1097/IAE.0000000000002843.
2
Photodynamic Therapy for Circumscribed Choroidal Hemangioma in 79 Consecutive Patients: Comparative Analysis of Factors Predictive of Visual Outcome.79 例局限性脉络膜血管瘤的光动力疗法:预测视力结果的因素比较分析。
Ophthalmol Retina. 2020 Oct;4(10):1024-1033. doi: 10.1016/j.oret.2020.04.018. Epub 2020 Apr 25.
3
Photodynamic therapy with double duration for circumscribed choroidal haemangioma: functional and anatomical results based on initial parameters.双倍时间的光动力疗法治疗局限性脉络膜血管瘤:基于初始参数的功能和解剖结果。
Clin Exp Ophthalmol. 2018 Jul;46(5):495-501. doi: 10.1111/ceo.13096. Epub 2017 Dec 6.
4
Circumscribed Choroidal Hemangioma: Visual Outcome in the Pre-Photodynamic Therapy Era versus Photodynamic Therapy Era in 458 Cases.局限性脉络膜血管瘤:458 例患者在光动力疗法前时代与光动力疗法时代的视力结局。
Ophthalmol Retina. 2020 Jan;4(1):100-110. doi: 10.1016/j.oret.2019.08.004. Epub 2019 Aug 22.
5
High recurrence rate in patients with choroidal hemangioma treated with limited single spot photodynamic therapy during long-term follow-up.在长期随访中,接受有限单部位光动力疗法治疗的脉络膜血管瘤患者复发率高。
Acta Ophthalmol. 2020 Nov;98(7):679-686. doi: 10.1111/aos.14409. Epub 2020 Apr 14.
6
Photodynamic therapy with verteporfin for symptomatic circumscribed choroidal hemangioma: five-year outcomes.光动力疗法联合维替泊芬治疗症状性局限性脉络膜血管瘤:五年随访结果。
Ophthalmology. 2010 Aug;117(8):1630-7. doi: 10.1016/j.ophtha.2009.12.033. Epub 2010 Apr 24.
7
Evaluation of subretinal fluid absorption by optical coherence tomography in circumscribed choroidal hemangioma after photodynamic therapy with Verteporfin.维替泊芬光动力治疗后局限性脉络膜血管瘤视网膜下液吸收的光学相干断层扫描评估
Neuro Endocrinol Lett. 2004 Feb-Apr;25(1-2):109-14.
8
EFFICACY OF DOUBLE DOSE PHOTODYNAMIC THERAPY FOR CIRCUMSCRIBED CHOROIDAL HEMANGIOMA.双倍剂量光动力疗法治疗局限性脉络膜血管瘤的疗效。
Retina. 2019 Feb;39(2):392-397. doi: 10.1097/IAE.0000000000001967.
9
Photodynamic therapy for symptomatic circumscribed macular choroidal hemangioma in Chinese patients.光动力疗法治疗中国患者有症状的局限性脉络膜黄斑瘤。
Am J Ophthalmol. 2010 Nov;150(5):710-715.e1. doi: 10.1016/j.ajo.2010.05.016. Epub 2010 Aug 14.
10
Photodynamic therapy for symptomatic circumscribed choroidal hemangioma in 22 Chinese patients: A retrospective study.22 例中国患者症状性局限性脉络膜血管瘤的光动力疗法:回顾性研究。
Photodiagnosis Photodyn Ther. 2018 Dec;24:372-376. doi: 10.1016/j.pdpdt.2018.10.019. Epub 2018 Oct 28.

引用本文的文献

1
Radiotherapy for non-cancer diseases: benefits and long-term risks.放疗治疗非癌症疾病:获益与长期风险。
Int J Radiat Biol. 2024;100(4):505-526. doi: 10.1080/09553002.2023.2295966. Epub 2024 Jan 5.
2
New insights on circumscribed choroidal hemangioma: "bench to bedside".局限性脉络膜血管瘤的新认识:“从基础到临床”。
Graefes Arch Clin Exp Ophthalmol. 2024 Apr;262(4):1093-1110. doi: 10.1007/s00417-023-06179-x. Epub 2023 Jul 28.
3
[Incidentally detected small subretinal tumor].
Ophthalmologie. 2023 Oct;120(10):1053-1055. doi: 10.1007/s00347-023-01892-8. Epub 2023 Jul 6.
4
How to Manage a Patient with Ocular Metastases?如何管理眼部转移瘤患者?
Biomedicines. 2022 Nov 25;10(12):3044. doi: 10.3390/biomedicines10123044.